课题基金 / 基金详情

项目摘要

项目成果

Hedvig Hricak的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a renewal application for the Memorial Sloan-Kettering Cancer Center (MSKCC) R25T training grant program, "Molecular Imaging: Training for Oncology" (MITO), which began in 2002. In the last five years, molecular imaging has been established as an outstanding tool for fostering rapid progress in laboratory discovery as well as uniquely individualized patient care. The goal of our program is to train a new generation of imaging researchers, who are sufficiently facile in both modern cancer biology and imaging techniques to lead the rapid development of molecular imaging as a tool for laboratory discovery and individualized clinical care in oncology. The program is managed by an internal advisory committee composed of clinical and basic cancer researchers with experience in graduate medical education in oncology. A distinguished external advisory board composed of leading molecular imaging researchers provides continual feedback and advice. MSKCC offers a unique environment as one of the leading clinical cancer centers in the world that is closely integrated with a research institution (Sloan-Kettering Institute [SKI]). It has an extensive molecular imaging infrastructure, as well as multiple oncology directed PO1s, SPOREs and RO1s with integral imaging components that stress the multimodality biologic imaging of cancer. These research programs provide fertile ground for training and selecting projects for trainees. Mentors are drawn from a distinguished faculty of NCI-supported cancer researchers. Our training program makes use of relationships we have established between the molecular imaging group and basic laboratory programs in cancer biology, tumor immunology, molecular pathology, and molecular pharmacology. It also makes use of translational programs that have been initiated at MSKCC over the last five years, in image-guided intervention, clinical PET research, cyclotron radiochemistry and advanced image analysis including biomarker assessment. A specialized curriculum includes an individualized research program of basic, translational or clinical interdisciplinary research and the relevant molecular biology, research methodology, and advanced imaging methods. Tri-institutional graduate programs from Cornell Medical College, SKI and Rockefeller University provide didactic training. Our diversity enhancement plan offers equal opportunities for minorities and women and includes a MITO Minority Recruitment Committee, participation of the MSKCC Diversity officer, and leadership from the CCNY/MSKCC Partnership. Both basic science and clinical trainees will be recruited. A plan is in place to facilitate placement of our trainees as junior faculty in molecular imaging programs at academic institutions across the country.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/bc400322h
发表时间: 2013-11-20
期刊: BIOCONJUGATE CHEMISTRY
影响因子: 4.7
作者: [Emmetiere, Fabien, Irwin, Christopher, Viola-Villegas, Nerissa Therese, Longo, Valerie, Cheal, Sarah M., Zanzonico, Pat, Pillarsetty, NagaVaraKishore, Weber, Wolfgang A., Lewis, Jason S., Reiner, Thomas]
通讯作者: Reiner, Thomas
DOI: 10.2967/jnumed.113.127266
发表时间: 2014-01
期刊: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子: --
作者: [Thorek DL, Riedl CC, Grimm J]
通讯作者: Grimm J
DOI: 10.1053/j.semnuclmed.2011.02.002
发表时间: 2011-07
期刊: Seminars in nuclear medicine
影响因子: 4.9
作者: [Rice SL, Roney CA, Daumar P, Lewis JS]
通讯作者: Lewis JS
High Precision Imaging of Microscopic Spread of Glioblastoma with a Targeted Ultrasensitive SERRS Molecular Imaging Probe.
使用靶向超灵敏 SERRS 分子成像探针对胶质母细胞瘤的微观扩散进行高精度成像
DOI: 10.7150/thno.13842
发表时间: 2016
期刊: Theranostics
影响因子: 12.4
作者: [Huang R, Harmsen S, Samii JM, Karabeber H, Pitter KL, Holland EC, Kircher MF]
通讯作者: Kircher MF
14
    Molecular Imaging in Cancer Biology Training Program
    Molecular Imaging in Cancer Biology Training Program
    Molecular Imaging in Cancer Biology Training Program
    Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate Cancer
    海外基金